TradeLab S.p.A.

As of December 31, 2025, TradeLab S.p.A. carries a market capitalization of 19.73M, placing it among publicly traded companies globally. Its enterprise value stands at 19.22M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

TradeLab S.p.A.'s next confirmed earnings release is scheduled for March 3, 2027.

As of December 31, 2025, TradeLab S.p.A. has 5.45M shares outstanding.

As of December 31, 2025, TradeLab S.p.A. trades at a trailing price-to-earnings ratio of 73.36. The price-to-sales ratio is 3.29, and the price-to-book ratio stands at 2.99.

As of December 31, 2025, TradeLab S.p.A. trades at an EV/EBITDA multiple of 32.71 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.20 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 111.45 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 19.22M versus a market cap of 19.73M, with the gap driven by net debt and cash on the balance sheet.

As of December 31, 2025, TradeLab S.p.A. maintains a current ratio of 1.26, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 14.49, indicating elevated leverage, while an interest coverage ratio of 8.71 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended December 31, 2025, TradeLab S.p.A. posted a return on equity (ROE) of 7.58, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 2.32 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 3.43, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 6.73, useful for judging operating efficiency across full business cycles. The company generates approximately 176,549.06 in revenue per employee across its workforce of 34.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.31 indicates how many times TradeLab S.p.A. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended December 31, 2025, TradeLab S.p.A. recorded 146,037.00 in income tax expense. That works out to an effective tax rate of 35.19, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 414,977.00, leaving 268,940.00 in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, TradeLab S.p.A.'s stock has declined approximately 46.77% over the past 52 weeks. The 50-day moving average sits at 1.89, while the 200-day moving average is 2.87.

Over the twelve months ended December 31, 2025, TradeLab S.p.A. generated 6.00M in revenue and converted that into 268,940.00 in net income, yielding earnings per share of 0.05. EBITDA reached 587,607.00, while operating income came in at 172,492.00.

As of December 31, 2025, TradeLab S.p.A. holds 1.46M in cash and equivalents against 957,065.00 in total debt, resulting in a net debt position of 294,504.00. Total book value stands at 6.61M, with working capital of 1.04M providing operational flexibility.

Over the twelve months ended December 31, 2025, TradeLab S.p.A. posted a gross margin of 85.67, reflecting its pricing power and cost economics. The operating margin of 2.87 and net profit margin of 4.48 provide insight into operational efficiency.

As of December 31, 2025, TradeLab S.p.A. has an Altman Z-Score of 4.17, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.